QA: Forte Biosciences Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001419041_2022_Forte_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001419041')"}

Graph

Absolute values for 0001419041, Forte Biosciences Inc.

  xvar xval
0 AssetsCurrent 42,520,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 786,000
4 LiabilitiesCurrent 1,758,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,633,000
9 ResearchAndDevelopmentExpense 13,853,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -222,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 43,306,000
1 Liabilities 1,758,000
2 Expenses 21,486,000
3 Revenues 0
4 StockholdersEquity 41,548,000
5 NetIncome -21,708,000
6 ComprehensiveNetIncome -21,708,000
7 BaseVar 33,386,000
8 EconomicCapitalRatio 2.21

Edgar->Model Mapping

Feature Distribution

Change over Time